SUPRAFLEX CRUZ Sirolimus Eluting Coronary Stent System
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SUPRAFLEX CRUZ Sirolimus Eluting Coronary Stent System, covering 2025-06-17 to 2025-06-17. Get the full timeline:
Most recent: Clinical Trial Update: Post-Market Registry to Evaluate the Safety and Efficacy of the The SUPRAFLEX CRUZ™ Sirolimus Eluting Coronary Stent System in the Treatment of an Octo- and Nonagenerian All-Comer Patient Cohort With Coronary Artery Disease - the Cruz Senior Study